Publications by authors named "C Bassez"

Claim this Profile
B
Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.
Pierre Deharo, Jacques Quilici, Laurence Camoin-Jau, Thomas W Johnson, Clémence Bassez

JACC Cardiovasc Interv· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.
Thomas Cuisset, Pierre Deharo, Jacques Quilici, Thomas W Johnson, Stéphanie Deffarges, Clémence Bassez

Eur Heart J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors.
Pierre Deharo, Mathieu Pankert, Jacques Quilici, Guillaume Bonnet, Clemence Bassez

Int J Cardiol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of switching 'low responders' to prasugrel to ticagrelor after acute coronary syndrome.
Clémence Bassez, Pierre Deharo, Mathieu Pankert, Guillaume Bonnet, Jacques Quilici

Int J Cardiol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrel.
Pierre Deharo, Mathieu Pankert, Guillaume Bonnet, Jacques Quilici, Clemence Bassez

Int J Cardiol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis